Nemolizumab for treating moderate to severe atopic dermatitis in people 12 years and over

Final draft guidance

Final draft guidance (PDF 192 KB)

Committee papers (PDF 1.11 MB)

Public committee slides (PDF 374 KB)

Draft guidance: 1

Draft consultation document (downloadable version) (PDF 208 KB)

Committee papers (PDF 4.93 MB)

Public committee slides (PDF 651 KB)

Equality impact assessment (downloadable version) (PDF 128 KB)

Final scope (PDF 129 KB)

Final stakeholder list (PDF 175 KB)

Equality impact assessment (scoping) (PDF 103 KB)

Draft scope post referral (PDF 214 KB)